AXT Inc ((AXTI)) has held its Q1 earnings call. Read on for the main highlights of the call.
Meet Samuel – Your Personal Investing Prophet
High conviction AXTI bulls now have this Tradr ETFAXT Inc.’s latest earnings call struck a distinctly upbeat tone, highlighting strong revenue growth, a surging indium phosphide backlog and a sharp swing toward profitability, even as management acknowledged execution risks. Investors were reminded that export permit uncertainty, heavy capital spending and complex product transitions could still inject volatility into quarterly results, but the company argued that mounting demand tied to AI and optical networking creates a compelling runway.
Revenue Growth
AXT reported Q1 2026 revenue of $26.9 million, up from $23.0 million in the prior comparable period and $19.4 million a year earlier, translating to about 17% sequential and 39% year-over-year growth. Management framed the topline acceleration as evidence that demand is broadening beyond a narrow set of customers and that prior investment in capacity and technology is beginning to show through the income statement.
Indium Phosphide Strength & Mix
Indium phosphide was the star of the quarter, generating $13.6 million in revenue and accounting for just over half of total sales, which materially boosted margins. The company underscored a backlog exceeding $100 million for indium phosphide substrates, positioning this segment as the primary growth engine as data center, AI and optical communication applications move to higher-performance materials.
Margin Expansion
Profitability metrics showed dramatic improvement, with non-GAAP gross margin rising to 29.9% and GAAP gross margin at 29.6%. That compares with a 21.5% non-GAAP margin in the preceding period and a negative 6.1% non-GAAP margin a year ago, a multi-year-style swing that management attributed to better product mix, higher utilization and improved manufacturing efficiency.
Narrowing Losses and Path to Profitability
Non-GAAP operating loss narrowed sharply to $0.55 million from $2.6 million in the prior period and roughly $9.6 million in the year-ago quarter, while non-GAAP net loss fell to $0.585 million, or $0.01 per share. AXT guided investors to expect both GAAP and non-GAAP profitability in the second quarter, with projected non-GAAP EPS of $0.06 to $0.08 and GAAP EPS of $0.05 to $0.07, signaling a near-term break into the black.
Substantial Capital Raise
To underpin its expansion plans, AXT completed a sizable $632.5 million capital raise, a remarkable sum relative to its current revenue base. Management said the funds will primarily fuel Tongmei’s indium phosphide capacity build-out, support research and development including the move to 6-inch wafers and bolster working capital as the company ramps production.
Aggressive Capacity Expansion Plan
The company is moving ahead of schedule on a multi-stage capacity expansion that aims to double indium phosphide output in 2026, targeting about $35 million per quarter of capacity by the end of that year. By 2027, AXT is planning for roughly $65 million to $70 million per quarter in capacity, implying exit annualized levels near $280 million and signaling confidence in sustained demand from AI and optical markets.
Raw Materials & Vertical Integration
AXT emphasized its vertical integration strategy, highlighting that subsidiary Jinmei has begun refining high-purity indium, a critical feedstock for indium phosphide substrates. This move is intended to secure supply, stabilize costs and provide a competitive edge by ensuring consistent quality and availability of key raw materials in a market where supply disruptions could be costly.
Geographic & Customer Momentum
Asia Pacific accounted for 78% of Q1 revenue, reflecting the company’s deep ties to optical and semiconductor supply chains in the region, while the top five customers represented about 32% of sales with no single customer above 10%. Management pointed to growing engagements with tier-one customers and hyperscalers and noted improved visibility and longer-term supply discussions, suggesting a broadening and deepening of its commercial footprint.
Export Permits and Geopolitical Uncertainty
Despite operational gains, management flagged China export permits as the single largest swing factor for revenue recognition and growth, with some U.S.-related permits still pending. The timing and approval of these licenses lie outside the company’s control, and executives cautioned that any delays or denials could materially impact quarterly performance even when underlying demand remains strong.
Concentration in Asia Pacific
The company acknowledged that its 78% revenue concentration in Asia Pacific creates regional and geopolitical exposure, particularly given regulatory friction between major economies. While AXT is working to diversify its customer and geographic base over time, investors were reminded that near-term growth remains heavily tied to China and broader Asia, a dependency that could amplify volatility.
CapEx Intensity and Future Funding Needs
Management laid out a CapEx roadmap that underscores the scale of its ambitions, estimating about $30 million to $40 million of spending in 2026 and roughly $100 million in 2027 for an adjacent facility build-out. Beyond that, a possible greenfield project in the $220 million to $250 million range is being contemplated, underscoring the capital intensity and execution risk even after the recent fundraising.
Working Capital & Inventory Build
As capacity ramps, working capital demands are rising, with cash, equivalents and investments down by $5.1 million to $123 million in Q1 while net inventory climbed about $8.5 million to $90.2 million. Management portrayed the inventory build as a deliberate move to support future shipments and shorten lead times, but it also heightens balance-sheet risk if permit or demand timing slips.
Dependence on Export Licenses for Gallium Arsenide Opportunity
Beyond indium phosphide, AXT sees attractive demand for gallium arsenide in industrial robotics, RF and data center laser uses, but expansion is constrained by export license availability. The company noted that gallium arsenide export licenses were limited in Q1, reinforcing how regulatory bottlenecks can cap upside even when end-market demand appears robust.
Legacy Losses and Near-Term Uncertainty
Although the earnings trend is improving, AXT still posted a GAAP net loss of $1.6 million in Q1, showing that a durable profit track record has yet to be established. Management stressed that future profitability will depend on favorable permit timing, maintaining a strong revenue mix and continuing to enhance manufacturing efficiency, leaving some near-term uncertainty despite encouraging momentum.
Product Transition & Manufacturing Complexity
The compound semiconductor market is shifting from 3-inch toward 4-inch and eventually 6-inch wafers, a transition that AXT is working to navigate while backlog remains skewed roughly four-to-one in favor of 3-inch. The company highlighted the technical and qualification challenges of ramping 6-inch production and managing different doping schemes, acknowledging that any missteps could affect yields, margins and customer timelines.
Listing/IPO Uncertainty
Management reiterated plans to list Tongmei on China’s STAR Market but cautioned that geopolitical and regulatory conditions could influence both timing and outcome. While such a listing could unlock additional capital and local visibility, the company framed it as one of several moving pieces rather than a guaranteed near-term catalyst, reflecting a cautious stance in a fluid policy environment.
Forward-Looking Guidance
Guidance for the second quarter leans bullish, with management expecting sequential revenue growth led by indium phosphide and projecting Q2 to be its largest indium phosphide quarter ever. Backed by a backlog above $100 million and roughly $34 million of revenue already cleared or not requiring permits, AXT is forecasting non-GAAP net income per share of $0.06 to $0.08 and GAAP net income per share of $0.05 to $0.07, while stressing that favorable permit decisions could unlock additional upside.
AXT’s earnings call painted a picture of a company riding strong secular demand in AI and optical communications while wrestling with regulatory, capital and manufacturing challenges. For investors, the story hinges on whether management can convert a deep indium phosphide backlog and aggressive capacity build-out into sustainable profitability, despite export permit uncertainty and regional concentration that could keep volatility high in the quarters ahead.